Horizon to license haploid models to Abcam in deal worth up to $3m
Horizon Discovery, a UK CRO, will license its cell lines to Abcam for use validating antibodies for up to $3m.
Archives for September 8, 2015
Anti-PCSK9 approvals a boon to Protein A supplier Repligen, says analyst
Repligen could reap the financial rewards from two recently approved cholesterol-lowering proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors, a Jefferies analyst says.
Epirus to buy CHO tech and biosimilar developer Bioceros
Epirus Biopharmaceuticals will bolster its biosimilar pipeline and gain a CHO platform through a $14m acquisition of Bioceros Holding.
Aragen Bioscience licenses protein yield boosting tech for cell line development
ProteoNic Biotechnology BV has licensed its protein production technology to US contractor Aragen Bioscience.
Genticel granted US patent for cancer vaccine delivery tech
Vaccine developer Genticel has been granted a US patent protecting the use of CyaA-based antigen delivery vectors in combination cancer therapies.